Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)

Market Cap	10.89B -12.0%
Revenue (ttm)	5.22B +0.8%
Net Income	651.95M +5.2%
EPS	0.73 +4.5%
Shares Out	881.71M
PE Ratio	16.92
Forward PE	11.41
Dividend	0.30 (2.46%)
Ex-Dividend Date	Jun 11, 2026

Volume	9,193,700
Open	12.20
Previous Close	12.20
Day's Range	12.10 - 12.49
52-Week Range	12.11 - 22.25
Beta	0.03
Analysts	Buy
Price Target	20.71 (+67.69%)
Earnings Date	Aug 6, 2026

About SHA:603456

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecule, drug product, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, and scientific research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1973
• Employees: 4,791
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603456

Financial Performance

In 2025, SHA:603456's revenue was 5.51 billion, an increase of 6.74% compared to the previous year's 5.16 billion. Earnings were 730.07 million, an increase of 20.46%.

Analyst Summary

According to 3 analysts, the average rating for 603456 stock is "Buy." The 12-month stock price target is ¥20.71, which is an increase of 67.69% from the latest price.

Price Target

¥20.71

(67.69% upside)

Analyst Consensus: Buy